Bone Density Conservation Agents

"Bone Density Conservation Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

Descriptor ID	D050071
MeSH Number(s)	D27.505.696.242
Concept/Terms	Bone Density Conservation Agents Bone Density Conservation Agents Antiresorptive Agents Antiresorptive Agents Bone Resorption Inhibitors Inhibitors, Bone Resorption Resorption Inhibitors, Bone Bone Resorption Inhibitory Agents Antiresorptive Drugs

Below are MeSH descriptors whose meaning is more general than "Bone Density Conservation Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Bone Density Conservation Agents [D27.505.696.242]

Below are MeSH descriptors whose meaning is more specific than "Bone Density Conservation Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bone Density Conservation Agents" by people in this website by year, and whether "Bone Density Conservation Agents" was a major or minor topic of these publications.

Bar chart showing 147 publications over 16 distinct years, with a maximum of 20 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	3	2	5
2006	5	2	7
2007	8	4	12
2008	15	5	20
2009	5	5	10
2010	4	7	11
2011	12	4	16
2012	10	4	14
2013	10	1	11
2014	7	3	10
2015	6	3	9
2016	5	3	8
2017	3	2	5
2018	2	1	3
2019	3	2	5
2020	1	0	1

Below are the most recent publications written about "Bone Density Conservation Agents" by people in Profiles.

Coleman R, Zhou Y, Chan A. Adjuvant denosumab in early breast cancer - Authors' reply. Lancet Oncol. 2020 03; 21(3):e125.

View in: PubMed
Wang JY, Huo L, Yu RQ, Rao NJ, Lu WW, Zheng LW. Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid. Biomed Res Int. 2019; 2019:5138175.

View in: PubMed
Coleman R, Finkelstein DM, Barrios C, Martin M, Iwata H, Hegg R, Glaspy J, Periañez AM, Tonkin K, Deleu I, Sohn J, Crown J, Delaloge S, Dai T, Zhou Y, Jandial D, Chan A. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):60-72.

View in: PubMed
Coleman R. Clinical benefits of bone targeted agents in early breast cancer. Breast. 2019 Nov; 48 Suppl 1:S92-S96.

View in: PubMed
Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, Edwards BJ, Frank E, Lyman GH, Smith MR, Mhaskar R, Henderson T, Neuner J. Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 11 01; 37(31):2916-2946.

View in: PubMed
Westbrook JA, Wood SL, Cairns DA, McMahon K, Gahlaut R, Thygesen H, Shires M, Roberts S, Marshall H, Oliva MR, Dunning MJ, Hanby AM, Selby PJ, Speirs V, Mavria G, Coleman RE, Brown JE. Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. J Pathol. 2019 03; 247(3):381-391.

View in: PubMed
Khairallah P, Nickolas TL. Updates in CKD-Associated Osteoporosis. Curr Osteoporos Rep. 2018 12; 16(6):712-723.

View in: PubMed
Asi KW, Abdelmeguid A, Bell D, Hanna EY. Massive aneurysmal bone cyst of the skull base treated with denosumab. Head Neck. 2018 12; 40(12):E107-E113.

View in: PubMed
Rachner TD, Coleman R, Hadji P, Hofbauer LC. Bone health during endocrine therapy for cancer. Lancet Diabetes Endocrinol. 2018 11; 6(11):901-910.

View in: PubMed
Schiodt M, Vadhan-Raj S, Chambers MS, Nicolatou-Galitis O, Politis C, Coropciuc R, Fedele S, Jandial D, Zhang J, Ma H, Saunders DP. A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Support Care Cancer. 2018 Jun; 26(6):1905-1915.

View in: PubMed

People

Explore

Similar Concepts

Top Journals